Found: 40
Select item for more details and to access through your institution.
Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2181, doi. 10.1007/s00277-023-05309-z
- By:
- Publication type:
- Article
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2059, doi. 10.1007/s00277-023-05340-0
- By:
- Publication type:
- Article
Association between N-acetylcysteine treatment and in-hospital mortality in adult patients with acquired thrombotic thrombocytopenic purpura: a cohort study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2257, doi. 10.1007/s00277-023-05295-2
- By:
- Publication type:
- Article
Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2225, doi. 10.1007/s00277-023-05333-z
- By:
- Publication type:
- Article
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2127, doi. 10.1007/s00277-023-05306-2
- By:
- Publication type:
- Article
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2119, doi. 10.1007/s00277-023-05304-4
- By:
- Publication type:
- Article
Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2153, doi. 10.1007/s00277-023-05301-7
- By:
- Publication type:
- Article
Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2299, doi. 10.1007/s00277-023-05327-x
- By:
- Publication type:
- Article
Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2241, doi. 10.1007/s00277-023-05324-0
- By:
- Publication type:
- Article
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2297, doi. 10.1007/s00277-023-05323-1
- By:
- Publication type:
- Article
Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2199, doi. 10.1007/s00277-023-05318-y
- By:
- Publication type:
- Article
Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2097, doi. 10.1007/s00277-023-05317-z
- By:
- Publication type:
- Article
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
- By:
- Publication type:
- Article
Basic mechanisms and novel potential therapeutic targets for ferroptosis in acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 1985, doi. 10.1007/s00277-023-05293-4
- By:
- Publication type:
- Article
Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2213, doi. 10.1007/s00277-023-05281-8
- By:
- Publication type:
- Article
Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2087, doi. 10.1007/s00277-023-05280-9
- By:
- Publication type:
- Article
Global profile of anemia during pregnancy versus country income overview: 19 years estimative (2000–2019).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2025, doi. 10.1007/s00277-023-05279-2
- By:
- Publication type:
- Article
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2137, doi. 10.1007/s00277-023-05278-3
- By:
- Publication type:
- Article
Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2051, doi. 10.1007/s00277-023-05289-0
- By:
- Publication type:
- Article
PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2189, doi. 10.1007/s00277-023-05292-5
- By:
- Publication type:
- Article
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2251, doi. 10.1007/s00277-023-05290-7
- By:
- Publication type:
- Article
Therapy results in pediatric Hodgkin lymphoma — does less mean better? Experience from a single children's oncology center.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2109, doi. 10.1007/s00277-023-05268-5
- By:
- Publication type:
- Article
Myeloid sarcoma: more and less than a distinct entity.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 1973, doi. 10.1007/s00277-023-05288-1
- By:
- Publication type:
- Article
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2001, doi. 10.1007/s00277-023-05286-3
- By:
- Publication type:
- Article
Emergence of maribavir resistance after CMV treatment in hematopoietic stem cell transplant recipient.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2283, doi. 10.1007/s00277-023-05265-8
- By:
- Publication type:
- Article
CD200 expression in T cell neoplasms.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2285, doi. 10.1007/s00277-023-05264-9
- By:
- Publication type:
- Article
Comparison of haploidentical–allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2015, doi. 10.1007/s00277-023-05256-9
- By:
- Publication type:
- Article
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2287, doi. 10.1007/s00277-023-05253-y
- By:
- Publication type:
- Article
Establishment of the Abu Dhabi Emirate Thalassemia Longitudinal Cohort (AD-TLC): leveraging the power of observation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2277, doi. 10.1007/s00277-023-05252-z
- By:
- Publication type:
- Article
N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2069, doi. 10.1007/s00277-023-05248-9
- By:
- Publication type:
- Article
Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2039, doi. 10.1007/s00277-023-05240-3
- By:
- Publication type:
- Article
Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2271, doi. 10.1007/s00277-023-05244-z
- By:
- Publication type:
- Article
Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2165, doi. 10.1007/s00277-023-05250-1
- By:
- Publication type:
- Article
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2077, doi. 10.1007/s00277-023-05180-y
- By:
- Publication type:
- Article
Myomatous erythrocytosis syndrome—an uncommon cause of secondary polycythemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2275, doi. 10.1007/s00277-023-05176-8
- By:
- Publication type:
- Article
An adult case of systemic lupus erythematosus and cerebral vasculitis after umbilical cord blood transplantation for acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2293, doi. 10.1007/s00277-023-05229-y
- By:
- Publication type:
- Article
Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2267, doi. 10.1007/s00277-023-05219-0
- By:
- Publication type:
- Article
Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2291, doi. 10.1007/s00277-023-05215-4
- By:
- Publication type:
- Article
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2279, doi. 10.1007/s00277-023-05214-5
- By:
- Publication type:
- Article
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2033, doi. 10.1007/s00277-023-05210-9
- By:
- Publication type:
- Article